£288
vs Aug 2024Active15105552Private limited companyHarrow
ALYDPHARMA LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
01
Summary
ALYDPHARMA LTD is an active private limited company (company number 15105552) incorporated on 30 August 2023, registered in Harrow. Its registered activity is dispensing chemist in specialised stores (SIC 47730). Latest micro accounts cover the period ending 31 August 2025, showing net assets of £288, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 106% on the prior period (−£4,766).
Peer position · net assets
By net assets it sits in the lower half of 900 comparable companies in Greater London (median £16k, upper quartile £276k).
02
Key dates
- Incorporated
- 30 August 20233 yrs ago
- Next accounts due
- 31 May 2027in 221 days
- Confirmation statement due
- 13 September 2027in 326 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 47730
- Dispensing chemist in specialised stores
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not disclosed
0
−100%vs Aug 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | £288 | — | — | £2,768 | — | — | 0 |
| 31 August 2024 | −£4,766 | — | — | £4,882 | — | — | 1 |
Current ratio1.1Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
05
Filing and accounts signals
- Positive net assetsNet assets £288 at 2025-08-31
- Net assets growing+106.0% vs prior period
- Incorporated two to five years agoIncorporated 2023-08-30
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
06
Ownership and control
- Mr Omar Mohamed Alloualid
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 326 days
- Next accounts duein 221 days
- Accounts period endNet assets £288 · micro accounts
- Accounts period endNet liabilities £4,766 · micro accounts
- Incorporated
08
Similar companies in Greater London
09
Reminders for ALYDPHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.